14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $23.53 $28.69 Friday, 3rd May 2024 INSM stock ended at $25.55. This is 0.429% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.06% from a day low at $25.40 to a day high of $26.43.
90 days $23.53 $29.91
52 weeks $18.09 $32.00

Historical Insmed prices

Date Open High Low Close Volume
Dec 08, 2023 $27.81 $28.20 $27.45 $27.96 1 855 289
Dec 07, 2023 $27.17 $27.78 $27.01 $27.57 2 021 411
Dec 06, 2023 $27.72 $28.32 $27.26 $27.27 1 677 792
Dec 05, 2023 $26.68 $27.72 $26.62 $27.48 1 959 911
Dec 04, 2023 $26.50 $27.03 $26.28 $26.97 1 944 439
Dec 01, 2023 $24.96 $26.53 $24.51 $26.52 1 674 238
Nov 30, 2023 $25.18 $26.23 $24.78 $25.02 1 314 002
Nov 29, 2023 $23.92 $25.17 $23.92 $25.10 1 762 862
Nov 28, 2023 $23.90 $24.12 $23.55 $23.80 858 232
Nov 27, 2023 $23.84 $24.21 $23.62 $23.94 1 487 690
Nov 24, 2023 $23.73 $24.21 $23.67 $24.03 384 686
Nov 22, 2023 $24.70 $24.70 $23.73 $23.73 771 249
Nov 21, 2023 $24.52 $24.89 $24.19 $24.37 721 199
Nov 20, 2023 $25.13 $25.22 $24.49 $24.62 844 661
Nov 17, 2023 $24.65 $25.05 $24.42 $24.82 1 580 947
Nov 16, 2023 $24.81 $24.97 $24.28 $24.44 1 552 948
Nov 15, 2023 $24.20 $25.21 $24.08 $24.90 1 191 685
Nov 14, 2023 $24.55 $24.90 $24.06 $24.54 1 271 051
Nov 13, 2023 $23.48 $23.91 $23.25 $23.90 803 537
Nov 10, 2023 $23.43 $24.01 $23.21 $23.75 747 169
Nov 09, 2023 $23.79 $23.79 $23.04 $23.42 962 235
Nov 08, 2023 $24.44 $24.44 $23.66 $23.75 971 005
Nov 07, 2023 $24.03 $24.63 $23.94 $24.40 1 217 818
Nov 06, 2023 $24.90 $25.09 $23.83 $23.84 910 174
Nov 03, 2023 $25.35 $25.60 $24.83 $24.85 1 431 718
Click to get the best stock tips daily for free!

About Insmed

Insmed Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutr... INSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT